Perfluoroalkyl acids (PFAAs) are widely distributed and environmentally persistent agents whose potential toxicity is not yet fully characterized. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid elicit a number of potential toxicities in rodents, the most prevalent of which are governed by activation of the peroxisome proliferator-activated receptor alpha (PPARa). The purpose of this investigation was twofold: (1) To conduct a structure-activity relationship study of the transcriptional activation of peroxisome proliferation in primary rat liver cell cultures for PFAA-related carboxylic and sulfonic acids of varying carbon chain length and (2) to explore whether this activity can be translated to human liver cells in culture. Exposure to PFOA caused a dose-dependent stimulation of the expression of acylCoA oxidase (Acox), Cte/Acot1, and Cyp4a1/11 transcripts that are indicative of peroxisome proliferation in primary rat hepatocytes. PFOA concentrations of 30mM and above caused cell injury characterized by the expression of Ddit3. Perfluorobutanoic acid (PFBA), on the other hand, stimulated Acox, Cte/ Acot1, and Cyp4a1/11 gene expression in primary rat hepatocytes only at concentrations of 100mM and above. Neither PFOA nor PFBA at concentrations up to 200mM stimulated PPARa-related gene expression in either primary or HepG2 human liver cells. These data demonstrate that (1) PFFAs cause a concentrationand chain length-dependent increase in expression of gene targets related to cell injury and PPARa activation in primary rat hepatocytes, (2) the sulfonates are less potent than the corresponding carboxylates in stimulating PPARa-related gene expression in rat hepatocytes, and (3) stimulation of PPARamediated gene transcription is a mechanism that is not shared by human liver cells, adding further substantiation that PPARadependent liver toxicity in rodents does not extrapolate to assessing human health concerns.
Perfluoroalkyl acids (PFAAs) are employed in the synthesis and production of a wide variety of surface-active products, mostly for oil and stain repellant applications. Recently, this family of chemicals has come under close scrutiny for their potential environmental health concerns. The free acids, such as perfluorooctanoic acid (PFOA) and perfluorosulfonate (PFOS), are terminal breakdown metabolites of variously substituted esters and amides and are resistant to both biological and environmental degradation; consequently, the unsubstituted acids are long-lived in the environment. Residues of PFOA and/or PFOS have been detected in a host of biological matrices harvested globally; these include the sera and tissues of most mammalian, aquatic, and avian species examined (Giesy et al., 2001) . This broad penetration of stable PFAAs in the environment has, in turn, prompted investigation into the possible toxicity associated with these exposures, a concern that is compounded by the detection of residual parts per billion concentrations of PFOA and PFOS in human sera (Butenhoff et al., 2006; Calafat et al., 2006; Harada et al., 2007; Karrman et al., 2006) .
High-dose acute animal toxicity testing for PFOA and PFOS has revealed a number of potential adverse effects, the scope of which includes interference with lipid and carbohydrate metabolism, cachexia, peroxisome proliferation, hepatomegaly, alteration of thyroid status, immune system effects, developmental delays, and adenomas of the liver, thyroid and pancreatic acinar cells (Andersen et al., 2008; Kennedy et al., 2004; Kudo and Kawashima, 2003; Lau et al., 2004) . The effects of PFOA and PFOS on intermediary metabolism and peroxisome proliferation resemble the biological response associated with administering fibric acid lipid-lowering drugs. Furthermore, the amphipathic and acidic nature of PFAAs is consistent with the structural discriminators of classic peroxisome proliferator compounds, suggesting that the biological response likely reflects ligand binding and transactivation of the peroxisome proliferator-activated receptor (PPAR), of which there are three distinct isoforms (PPARa, PPARb/d, and PPARc) . In fact, PFOA and PFOS have been demonstrated to be ligands for and to transactivate PPARa and, to a lesser extent, PPARb/d and PPARc (Maloney and Waxman, 1999; Takacs and Abbott, 2007; Vanden Heuvel et al., 2006) .
Discriminative analysis reveals that the majority of reported effects of PFAAs can be attributed to the PPARa activation pathway (Andersen et al., 2008; Klaunig et al., 2003) . Experiments with transgenic PPARa knockout mice demonstrate that the effects of PFOA on neonatal development, food consumption, immunomodulation, and hepatic peroxisome proliferation are all attributed to activation of PPARa; however, PPARa knockout mice exposed to PFOA still develop hepatomegaly, which is associated with cellular vacuolation (Abbott, 2008; Abbott et al., 2007; Asakawa et al., 2008; Rosen et al., 2008a Rosen et al., , 2008b Wolf et al., 2008b; Yang et al., 2002) . Likewise, the tumorigenic, developmental, and immune system effects of PFOA and PFOS have also been attributed to PPARa activation Dewitt et al., 2009; Gonzalez and Shah, 2008; Yang et al., 2002 Yang et al., , 2007 . The significance of these findings is that humans lack a robust PPARa-dependent biological response, possibly because of the deficiency of PPARa protein (Palmer et al., 1998; Tugwood et al., 1996) or molecular discriminators of rodent versus human gene promoter effects (Yang et al., 2008) . Regardless, the most profound effects of PFOA and PFOS, as well as other peroxisome proliferator chemicals, seem to be rodent specific and of questionable relevance in addressing human toxicity concerns.
There exist a number of other structurally related PFAAs with lesser commercial applications and environmental penetrance compared to PFOA and PFOS, and for which, biological activity has only recently begun to be addressed. These include, for the most part, the linear carboxylic or sulfonic acids of varying carbon number, some of which have also been detected as residues in environmental samples (Calafat et al., 2006) . As an initial approach to exploring their biological activity, it may be hypothesized that, like the eight-carbon acids, these too are ligands for the PPARa nuclear receptor. Whether this is true of the entire linear series of PFAAs and its impact on human health risk assessment has yet to be addressed. Toward that end, this interspecies structure-activity investigation was designed to compare the PPARa-dependent transcriptional activation potential of the structural series of linear perfluorocarboxylic and sulfonic acids in rodent hepatocytes and to assess whether such biological activity extrapolates to human liver cells in vitro.
MATERIALS AND METHODS
PFAAs were supplied by the 3M Company (St Paul, MN) as dry powders with the exception of trifluoroacetic, perfluoropropionic, and perfluorobutyric acids, which were supplied as aqueous solutions. The dry compounds were dissolved in dimethyl sulfoxide (DMSO), and all compounds were diluted to a stock concentration of 50mM.
Cell cultures. Freshly isolated primary rat and human hepatocytes were purchased from CellzDirect (Durham, NC) and handled according to the vendor's recommendations. Upon receipt, cells were pelleted by centrifugation, and the proprietary cold storage medium was removed. The cells were resuspended in Dulbecco's minimum essential medium (DMEM) supplemented with 5% fetal bovine serum (FBS), 4 lg/ml insulin, and 0.1lM dexamethasone. Cell viability, assessed by trypan blue dye exclusion, was 70% for all cultures upon receipt. The hepatocytes were diluted to 3 3 10 6 cells per 5 ml of supplemented DMEM, plated on collagen-coated 25-cm 2 tissue culture flasks, and incubated at 37°C in 5% CO 2 . After 4 h, the media was removed by aspiration and replaced with 5 ml of serum-free William's E media supplemented with 6.25 lg/ml insulin, 6.25 lg/ml apo-transferrin, 6.25 ng/ml selenium, and 0.1lM dexamethasone and incubated overnight. After 24 h, the media was removed and replaced with 5 ml supplemented William's E media (serum free) to which the individual PFAA was added. An equal volume of DMSO was added to the control flasks; in all cases, the final concentration of DMSO was 0.1%. The flasks were returned to 5% CO 2 at 37°C for 24 h prior to RNA isolation.
HepG2/C3A cells were obtained from the American Type Culture Collection (Manassas, VA). The cells were grown in 25-cm 2 flasks with minimum essential medium (MEM) supplemented with 10% FBS. The cells were passaged at the estimated log growth phase until a sufficient number of 80-90% confluent 25-cm 2 flasks were obtained for each experiment. Exposure of HepG2/C3A cells to PFAAs was carried out in FBSsupplemented MEM under the same incubation conditions as with the primary hepatocyte cultures.
RNA isolation. RNA was isolated from cells (primary hepatocytes and HepG2/C3A cells) using an RNeasy mini kit (Qiagen, CA) according to the manufacturer's protocol. Media was aspirated from flasks, and cells were rinsed once with 5 ml PBS (pH 7.4). An aliquot of 600 ll Qiagen's lysis buffer (Buffer RLT with 10 ll/ml beta-mercaptoethanol) was added to each flask and swirled to coat the entire growth surface. A cell scraper was used to collect the lysate, which was transferred to 2-ml microcentifuge tubes. Lysate was homogenized with five passages through a 27-gauge stainless steel needle. Subsequent RNA cleanup steps were performed according to the manufacturer's protocol including an on-column DNAse digestion using the RNAsefree DNAse set (Qiagen). The RNA was eluted in 35 ll molecular biology grade water and quantified spectrophotometrically using the NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA). The ratio of 260-280 nm optical density was 2 or higher for all samples with typical nucleic acid spectral scans indicating good purification of the total RNA.
Reverse transcription PCR.
A two-step quantitative reverse transcription PCR (RT-PCR) process was used to quantify gene expression. Reverse transcription was performed using the Omniscript RT kit (Qiagen) according to the manufacturer's protocol. The reactions were carried out using nine base pair random primers (IDT, Coralville, IA) and either 1.0 or 1.5 lg of total RNA. The final reverse transcription reactions were diluted 1:10 with molecular biology grade water. The quantitative PCR reaction was performed with the LightCycler using the Sybr Green Master Mix Kit (Roche Applied Science, Indianapolis, IN). The PCR reaction consisted of 2 ll of the diluted RT reactions, 5 pmoles target-specific upper and lower primers, and 3 mM MgCl 2 in a final volume of 10 ll. A target-specific DNA standard was prepared for each transcript by performing a 150 ll PCR reaction using HotstarTaq PCR Master Mix Kit (Qiagen) and cleaning the product using the Qiaquick PCR Purification Kit (Qiagen) The purified DNA standard was visualized by running a 100 ng aliquot on a 1.5% agarose gel and verifying that a single product of the proper size was present. The DNA standard was quantified spectrophotometrically using the NanoDrop ND1000 and diluted to a standard stock concentration of 5 3 10 9 DNA copies per microliter. Quantitation of gene expression was achieved by measuring target messenger RNA (mRNA) copy number against a 10-fold serial dilution of target-specific DNA standard ranging between 10 7 and 10 3 DNA copies. The results were normalized to 18S ribosomal RNA copies, which was measured in subsequent LightCycler PCR reactions for each RT run.
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Primer design. Oligonucleotide primers for PCR were designed using Primer Quest software available at www.idtdna.com (IDT). GenBank accession numbers (www.ncbi.nlm.nih.gov) for target sequences were used, and the parameters for oligo design were set to select primer pairs with a predicted melting temperature close to 60°C and a PCR product size less than 200 base pairs in length when possible (Table 1) . Selection of primers pairs was also limited to PCR products spanning known intronic sequences.
Statistics. Treatment groups were analyzed for statistically significant differences from control by one-way ANOVA with replication followed by Dunnett's post hoc test (v. 3.0; GraphPad Software, San Diego, CA). Each individual primary rat hepatocyte isolation and each individual human donor were considered independent replications (n). For HepG2/C3A cells, each vial of a previously expanded and frozen master HepG2/C3A stock culture was considered an independent replicate (n). A probability of 0.05 was selected as the criterion for statistical significance.
RESULTS

Dose Response
Primary rat and human hepatocyte cultures, as well as HepG2/C3a hepatoma cells, were exposed to either PFOA or perfluorobutanoic acid (PFBA) over a dose range from 0 to 200lM for 24 h. Quantitative RT-PCR was used to measure the dose-dependent response in mRNA expression for acylCoA oxidase (Acox), cytochrome P450 omega fatty acid hydroxylation isoform (Cyp4a1, rats; Cyp4a11, human), acylCoA thioesterase (Cte, rats; Acot1, human), and DNA damage inducible (Ddit3; GADD153) transcripts (refer Table 1 for the specific primer sequences for rat and human homologues of Cyp4a and thioesterase transcripts). Induction of Acox and Cyp4a1 gene expression is associated with a transcriptional response to peroxisome proliferators; expression of both genes has been shown to be strongly induced in rodents by PFOA (Bjork et al., 2008; Rosen et al., 2008a Rosen et al., , 2008b . Cte/Acot1 codes for thioesterases, which are also PPARa-controlled genes and important regulators of lipid metabolism (Hunt et al., 1999 (Hunt et al., , 2002 . Gene expression of the mitochondrial and cytosolic isoforms of Cte/Acot1 in rodents is inducible by peroxisome proliferators, including PFOS (Bjork et al., 2008) . Ddit3 is an inducible gene expression marker for cell injury and has been demonstrated to be expressed in response to a variety of xenobiotic exposures associated with either direct (DNA reactive) or indirect (cell death) DNA damage (Los et al., 1999) . We employed Ddit3 as a means of setting the upper boundary of noncytotoxic PFAA concentration for analyzing PPARa-related gene expression.
In primary rat hepatocytes, PFOA caused a concentrationdependent increase in Ddit3 gene expression at 20lM with a maximum increase of 13-fold observed at 200lM (Fig. 1) . In primary human hepatocytes, PFOA exposure caused a more modest increase in Ddit3 gene expression, which was induced sevenfold at 200lM PFOA (p 0.05). Ddit3 gene expression was unaltered by PFOA in HepG2/C3A human hepatoma cells below 200lM (90 ppm). In contrast to PFOA, PFBA did not induce significant Ddit3 gene expression at any concentration in primary rat, primary human, or HepG2/C3a cells, indicating an absence of PFBA-induced DNA damage-related injury in any of these cell cultures.
PFOA at concentrations up to 30lM stimulated Acox mRNA expression in primary rat hepatocytes; maximum Acox expression was 8.5-fold over control at 20lM (Fig. 2) . There was, however, a large degree of variability in these measures. The progressive decline in Acox gene expression observed for rat hepatocytes at PFOA concentrations greater than 30lM likely reflects a progressive and concentration-dependent cell injury as indicated by the corresponding increase in Ddit3 gene expression observed in these same cells (Fig. 1) . Expression of Acox in either primary or HepG2/C3a human liver cells was not significantly different from control across the entire range of PFOA exposure concentrations (Fig. 2) . Exposure to PFBA caused a concentration-dependent increase in Acox mRNA expression in primary rat hepatocytes from 50 to 200lM (7.3-fold induction over control at 200lM PFBA). In contrast, Acox mRNA expression was unaltered by PFBA in primary human hepatocytes and HepG2/C3a cells across the entire range of concentrations of PFBA (Fig. 2) .
PFOA stimulated Cte/Acot1 gene expression in primary rat hepatocytes at concentrations as low as 5lM (Fig. 3) ; the change was not statistically significant, however, below 20lM PFOA. Maximum stimulation of Cte/Acot1 gene expression in rat hepatocytes was 8-fold at 200lM PFOA. Likewise, PFBA (Fig. 3) . In primary rat hepatocytes, Cyp4a1 gene expression exhibited a biphasic response to increasing concentrations of PFOA (Fig. 4) , similar to that observed for Acox, with a 46-fold increase in Cyp4a mRNA1 at 30lM. Stimulation of Cyp4a1 gene expression in rat hepatocytes was a sensitive molecular indicator of PFOA exposure, showing a near 40-fold induction over controls at 5lM PFOA. The decline in Cyp4a1 gene expression at concentrations higher than 30lM again likely reflects a progressive PFOA-induced cell injury as indicated by the increasing Ddit3 gene expression (Fig. 1) . Induction of Cyp4a gene expression by PFOA in primary human hepatocytes resembled that of primary rat hepatocytes (Fig. 4) , although maximum expression in human hepatocytes was only 4.3-fold compared to 39.5-fold in rats. This difference reflects the higher constitutive expression of Cyp4a in humans compared to rats and is reflected by the expression of Cyp4a mRNA in control cells (Fig. 4) . Once again, the decline in Cyp4a gene expression in both rat and human liver cells at concentrations above 50 lm PFOA correlates with the concentration-dependent increase in Ddit3 gene expression (Fig.  1) , suggesting a progressive degree of cell injury. Similar to what was observed with PFOA, PFBA caused a concentrationdependent increase in Cyp4a1 mRNA copies in primary rat hepatocytes with a maximum of 43-fold increase over control at 200lM (Fig. 4) . In primary human hepatocytes, however, Cyp4a11 gene expression was unaltered by PFBA across the concentration range. Furthermore, in HepG2/C3a cells, Cyp4a11 was not expressed at quantifiable levels across the entire range of concentrations of either PFOA or PFBA.
It is important to note that for the Ddit3, Acox, and Cte/Acot1 transcripts, although the fold induction by PFBA may compare to that caused by PFOA, the absolute values (number of copies of mRNA per copy of 18S ribosomal RNA) for the maximum induction by PFBA were 3-to 10-fold lower than those for PFOA (compare scales for upper and lower panels of Figs. 1-3 ).
Structure-Activity Relationship
Primary rat and human hepatocytes and HepG2/C3A hepatoma cells were exposed to 25lM PFAAs for 24 h to evaluate the structure-activity relationships (SARs) across varying alkyl chain length in the context of PPARa-related gene expression. This concentration PFAAs was selected on the basis of the maximum concentration that did not induce cell injury in any of the cell lines as evidenced by the 
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BJORK AND WALLACE concentration-dependent stimulation of Ddit3 gene expression (Fig. 1) . The series of PFAAs used in these experiments are illustrated in Table 2 and include perfluorinated carboxylic acids with carbon chain length ranging from two to eight (trifluoroacetate to perfluorooctanoate) and perfluorinated sulfonic acids with chain length ranging from four to eight carbons long (perfluorobutane to perfluorooctane sulfonate).
It was only in primary rat hepatocytes that the PFAAs (25lM) stimulated expression of either Acox or Cte/Acot1 mRNA (Figs. 5 and 6 ). Furthermore, with both series and both transcripts, the degree of stimulation of gene expression increased with increasing carbon number through perfluorooctane; maximum stimulation of Acox gene expression was 7-fold over control by PFOA and 3-fold by PFOS (Fig. 5) . Neither PFBA nor perfluorobutane sulfonate (PFBS) caused a statistically significant increase in Acox gene expression in any of the cell types examined. Conversely, both PFBA and PFBS caused a significant (~50% increased) stimulation of Cte/Acot1 gene expression in primary rat hepatocytes (Fig. 6) . Maximum stimulation of Cte/Acot1 gene expression was 10-fold for PFOA and 4-fold for PFOS. PFOA caused a slight (50%), but statistically significant stimulation of Acox, but not Cte/Acot1, gene expression in primary human hepatocytes (Fig.  5) . Likewise, perfluorohexane sulfonate, but not perfluorohexanoic acid, PFOA, or PFOS, caused a statistically significant increase (40%) in Cte/Acot1 gene expression in primary human hepatocytes (Fig. 6) .
The Cyp4a11 gene was not constitutively expressed nor was expression stimulated by the PFAAs in HepG2/C3A cells (Fig. 7) . However, the expression of this gene was stimulated by PFAA exposure in both primary rat and human hepatocytes-the perfluorocarboxylates showing a chain length-dependent SAR. Maximum stimulation of gene expression was observed for the longer carbon chain PFAAs; however, the experimental variability was quite large and limited statistical discrimination between the six and the eight carbon molecules. As was observed for the Acox and Cte/Acot1, the magnitude of increase in mRNA was greater for the carboxylic than for the sulfonic PFAA.
For all transcripts examined, including Ddit3, the response of HepG2/C3A cells to PFOA was quantitatively less than that of the corresponding primary human hepatocytes. This difference may be ascribed, in part, to the fact that the primary cells were exposed in a serum-free media, whereas the exposure medium for HepG2/3CA cells was supplemented with 10% FBS. Because of protein binding, the effective dose of PFOA in the serum-supplemented medium is likely less than reported. However, we believe that the difference in sensitivity is more fundamental than simply a dosing phenomenon. For PFAA SAR AND HUMAN RELEVANCE 93 example, unlike the primary rat or human lever cells, Cyp4a11 is not constitutively expressed in unexposed HepG2/C3A cells (Figs. 4 and 7) . This then brings into question the suitability of HepG2/C3A cells as surrogates for investigating the mechanism(s) and/or capacity for PFAA-induced human liver toxicity.
DISCUSSION
Transactivation of PPARa is considered to be a critical pathognomic event in PFAA-induced toxicities in rodents. The majority of experiments investigating mechanisms of PFAA toxicity have been performed with the eight-carbon PFOA and PFOS; it is assumed that similar mechanisms are operative with other perfluoroalkyl acids. Biological activities associated with PFOA and PFOS that are ascribed to PPARa activation include peroxisome proliferation, hepatomegaly, decreased serum triglycerides and cholesterol, and nongenotoxic hepatocellular carcinogenesis (Andersen et al., 2008; Kennedy et al., 2004) . Of these, only hepatomegaly is observed in PPARa knockout mice, an effect that is ascribed to the accumulation of PFAAcontaining cytoplasmic vacuoles, not peroxisome proliferation or hepatocellular proliferation Wolf et al., 2008b; Yang et al., 2007 Yang et al., , 2008 . It is because of this generalized implication of PPARa activation as the primary and limiting mechanism of hepatotoxicity that we chose to focus on gene targets of PPARa activation as indices for assessing SARs for the biological activity of PFAAs in the different liver cell models. It is recognized, however, that some of the biological activity of PFOA, and presumably other PFAAs, has been ascribed to transactivation of nuclear receptors other than PPARa, such as the constitutive activated androstane receptor and pregnane X receptor (Cheng and Klaassen, 2008; Ren et al., 2009; Rosen et al., 2008a Rosen et al., , 2008b Vanden Heuvel et al., 2006) . Gene expression profiles have been used extensively to characterize the effects of PFOA and PFOS exposures in vivo in rodents (Bjork et al., 2008; Guruge et al., 2006; Rosen et al., 2008b; Shipley et al., 2004) . Gene families identified as PPARa discriminators include those associated with fatty acid b-oxidation (both peroxisomal and mitochondrial), cell proliferation, and apoptosis. Similar analyses have been used for primary rat liver cell cultures exposed to pharmaceutical-based peroxisome proliferators in vitro (WY14-643, clofibrate, ciprofibrate, and gemfibrozil) and have yielded comparable transcriptional profiles (Ammerschlaeger et al., 2004; Hu et al., 2005; Tamura et al., 2006) . These include increased expression of Acox, cytosolic acyl-CoA thioesterase (Cte/Acot1), and 
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BJORK AND WALLACE message for the Cyp4a family of proteins; the same transcripts employed in the current investigation. Intrasuksri and Feller (1991) were the first to investigate the effect of PFAAs in liver cell cultures. Exposure of rat primary hepatocytes to PFBA, PFOA, and perfluorodecanoic acid (PFDA) at 10-100lM in culture for 72 h caused a significant induction of fatty acyl CoA oxidase enzyme activity; the order of potency was PFOA > PFDA > PFBA. However, this receptor-specific induction of gene expression was confounded at higher concentrations that caused cell toxicity; 100lM PFDA, 300lM PFOA, and 1000lM PFBA (Intrasuksri and Feller, 1991) . Shabalina et al. (1999) observed a similar loss of cell viability in HepG2 cells exposed in culture to 200lM PFOA, which they attributed to the stimulation of apoptosis. These are all consistent with our observation of a dose-dependent increase in Ddit3 gene expression at concentrations of 100lM for PFOA but not at up to 200lM PFBA (Fig. 1) . It is important to note that at these high concentrations, the mechanism of cell killing by the PFAAs is unknown but likely nonspecific and unrelated to nuclear receptor activation. For these reasons, we restricted our analysis of gene expression to a concentration of PFAAs (25lM) below that which causes overt cytotoxicity. In vivo exposures to a series of PFAAs have revealed a carbon chain length-dependent induction of peroxisome proliferation in mice (Kozuka et al., 1991; Kudo et al., 2006) . In both studies, induction of peroxisome-related fatty acid oxidation enzyme activity increased with increasing carbon chain length, from perfluoroburtyric acid through perfluorodecanoic acid. Kudo et al. (2006) reported a similar carbon chain length SAR for the degree of accumulation of the PFAA in hepatocellular tissue, suggesting possibly that the SAR is simply a toxicokinetic phenomenon driven by internal dose of the respective PFAA. However, our observation, along with other reports of SAR activity in isolated cells in culture, 96 BJORK AND WALLACE demonstrates that this SAR is driven by a dynamic biological determinant as well. Wolf et al. (2008a) transfected COS-1 cells with either mouse or human PPARa receptor reporter plasmid then exposed to increasing concentrations of various PFAAs and observed a concentration-dependent activation of PPARa. The order of potency for mouse PPARa activation was perfluorononanoic acid PFOA > PFDA > perfluorohexanoic acid > PFBA and perfluorohexane sulfonate > PFOS > PFBS, with the carboxylic acids inducing a greater response than the corresponding sulfonates, as was observed in the present investigation. In all but perfluorohexane sulfonate, activation of mouse PPARa was statistically greater than human PPARa. These results compare favorably with those reported herein and indicate that the greater induction of peroxisome proliferation in vivo caused by the longer carbon chain and more lipophilic PFAAs is due to both toxicokinetic as well as cell level receptor-based dynamic determinants of the molecular response.
The results also demonstrate that the species difference in PPARa-regulated gene transcription is quantitative, not absolute, and specific to the individual transcripts. For example, similar to what we observed for Cyp4A11, Hsu et al. (2001) , Ammerschlaeger et al. (2004) , and Yang et al. (2008) reported that although human hepatocytes are relatively nonresponsive to PPARa-induced expression of genes related to cell or peroxisome proliferation, they do respond with increased expression of gene targets for fatty acid oxidation pathways (i.e., carnitine-palmitoyl transferase and 3-hydroxy-3-methylglutaryl-CoA synthase). Omega fatty acid hydroxylation, as catalyzed by Cyp4A11, would be expected to fall within this same category. Raucy et al. (2004) observed a more than 2-fold induction of Cyp4A11 transcription in primary human hepatocytes exposed in culture to clofibrate, suggesting the possibility of PPARa-dependent gene expression in humans. However, unlike the rat genome for which a peroxisome proliferator-response element (PPRE) consisting of direct repeat of TGACCT motifs separated by a single base pair 2-4 kbp upstream of the genes encoding bifunctional enzyme (Ehhadh) and Cyp4A1 (Aldridge et al., 1995; Bardot et al., 1993) , no such PPRE has been identified within the 5#-flanking region of the human Cyp4A11 gene (Kawashima et al., 2000) . Collectively, the evidence suggests that unlike the rat, expression of Cyp4A11-related omega fatty acid oxidation activity in humans is not regulated by PPARa or similar PPREbinding elements.
A particularly defining investigation regarding the species specificity of PPARa ligands was performed by Ammerschlaeger et al. (2004) who showed that the stimulation of expression of fatty acid oxidation-related genes in response to exposure in vitro to peroxisome proliferators is a characteristic of rat liver cells that is not shared by human HepG2 cells in culture. Similar to what we observed with the perfluoroalkyl acids, exposure of primary rat hepatocytes or FAO rat hepatoma cells in culture to WY14-643, clofibrate, or ciprofibrate results in a significant 5-to 20-fold increase in expression of Acox transcript, whereas there was less than 2-fold induction of Acox mRNA in either primary human or HepG2 liver cells. The relative nonresponsiveness of human liver cell lines to PPARa ligands may be attributed to the substantially lower constitutive expression of PPARa (Ammerschlaeger et al., 2004) . FIG. 7 . SAR between PFAAs of varying carbon chain length in primary rat, primary human, and HepG2/C3A human hepatoma cells. PFAA exposure was 25lM for 24 h. Values are Cyp4a1/11 mRNA copies per 18S ribosomal RNA copy. Asterisks indicate significant difference from controls (p < 0.05, Dunnett's). Error bars represent SEM (n ¼ 4).
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However, when human PPARa was overexpressed in human hepatocytes to levels comparable to those of rat PPARa measured in rat hepatocytes, PPARa ligands still failed to induce the expression of Acox mRNA, indicating that the species difference is due to more than PPARa transcript levels alone. Alternatively, both transient cell transfection experiments and humanized transgenic mouse models indicate that this marked species difference is due not only to species-specific differences in PPARa and PPRE but also to pleiotropic differences in the promoter regions for the individual gene targets and/or coregulators of gene expression (Ammerschlaeger et al., 2004; Gonzalez and Shah, 2008; Yang et al., 2008) . For example, transient transfection of either human PPARa or human PPRE abolishes the ligand-dependent stimulation of Acox gene expression in primary or transformed (FAO) rat hepatocytes (Ammerschlaeger et al., 2004) . Furthermore, transfection of both rat PPARa and rat PPRE in human hepatocytes is not sufficient to endow the cells with ligand-dependent stimulation of Acox expression, suggesting that factors beyond the nuclear receptor and response element are operative in defining this species difference in responsiveness to PPARa ligands.
In summary, the data reported herein demonstrate two fundamental principals governing PFAA-induced peroxisome proliferation: (1) Induction of PPARa-related gene expression by PFAAs in primary rat hepatocytes is a dynamic phenomenon that increases with carbon chain length and is greater for the carboxylic acids than the sulfonates and (2) induction of peroxisome-related fatty acid oxidation gene expression (Acox and Cte/Acot1) is not observed in either primary or transformed human liver cells in culture. These results extend previous reports to include nontransfected primary liver cells of both rat and human, providing further evidence discounting the relevance for PPARa-mediated peroxisome proliferation in rodent liver as a reference indicator of human risk.
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